PAR6 A COMPARISON OF HEALTH CARE COSTS IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA) WHO RECEIVED ETANERCEPT (ETA), ETA PLUS METHOTREXATE (MTX), INFLIXIMAB (INF), OR INF PLUS MTX
May 1, 2007, 00:00
10.1016/S1098-3015(10)68898-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)68898-5/fulltext
Title :
PAR6 A COMPARISON OF HEALTH CARE COSTS IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA) WHO RECEIVED ETANERCEPT (ETA), ETA PLUS METHOTREXATE (MTX), INFLIXIMAB (INF), OR INF PLUS MTX
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68898-5&doi=10.1016/S1098-3015(10)68898-5
First page :
Section Title :
Open access? :
No
Section Order :
72